Skip to main content

Plewman Patrick's Form 4 filing

Quest Diagnostics Inc (DGX) · filed Aug 8, 2025

Accession no.
0001497368-25-000005
Filed
Aug 8, 2025
Trade date
Aug 6, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $968.6K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Plewman PatrickCIK 0001497368Officer (SVP for Diagnostic Services)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 6, 2025Common StockMOption exerciseAcquired+3,560$86.63+$308,402.824,745Direct
Aug 6, 2025Common StockSSaleDisposed−3,560$175.00−$623,00021,185Direct
Aug 6, 2025Common StockSSaleDisposed−1,975$175.00−$345,62519,219Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 6, 2025Common StockMOption exerciseDisposed−3,560$86.63−$308,402.80Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)